FDA Approves Second Vaccine to Fight COVID-19

December 22, 2020

Inoculations of frontline healthcare workers to expand across the country with addition of Moderna vaccine

Last week, Moderna became the second pharmaceutical company in the United States to receive the Food and Drug Administration’s emergency use authorization (EUA) for its COVID-19 vaccine. The addition of the Moderna COVID-19 vaccine to the already emergency-authorized Pfizer-BioNTech COVID-19 vaccine will increase the number of people able to get vaccinated.
A recent survey finds 71% of Americans say they will “definitely or probably” get a COVID-19 vaccine when it’s available. That’s up from the 63% of respondents the Kaiser Family Foundation found in a previous September survey. Black Americans and people living in rural areas are among the populations more hesitant about getting vaccinated, according to the survey.
ISMIE offers a variety of resources to help you and your practice navigate during these challenging times. From how to talk to patients about why they need to wear a mask to wellness for healthcare professionals to other considerations that your practice may want to think about, our COVID-19 risk management resources provide comprehensive guidance, webinars, FAQs and more to help you navigate challenges during the ongoing pandemic.
If you have questions, please contact the Risk Management team by email.
Share this article:

Cookie Consent

Cookies are required for some functionality on our site. View our privacy policy for more information.